Berenberg Bank Issues Positive Forecast for Genus (LON:GNS) Stock Price

Genus (LON:GNS) had its price objective raised by Berenberg Bank from GBX 3,050 to GBX 3,250 in a report published on Friday morning, MarketBeat Ratings reports. Berenberg Bank currently has a buy rating on the stock.

GNS has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft upped their price target on shares of Genus from GBX 2,900 to GBX 3,100 and gave the company a “buy” rating in a research note on Wednesday, November 19th. Shore Capital boosted their price objective on Genus from GBX 2,900 to GBX 3,000 and gave the stock a “buy” rating in a report on Wednesday, November 19th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of GBX 3,116.67.

Genus Price Performance

LON:GNS opened at GBX 2,835 on Friday. The company has a market cap of £1.88 billion, a P/E ratio of 98.10, a P/E/G ratio of 2.87 and a beta of 0.37. The firm’s fifty day moving average price is GBX 2,548.09 and its two-hundred day moving average price is GBX 2,510.44. Genus has a one year low of GBX 1,548 and a one year high of GBX 3,228.80. The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.